Dose patients in the pivotal study of dipraglurant for PD-LID
Delivered by the deadline
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 17 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- 29 Jun 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“expect to dose patients in the first half 2021”
What we found
Evidence strength A What the grades mean
A later 6-K says the company announced initiation of the pivotal dipraglurant PD-LID trial on June 29, 2021, within the first half 2021 deadline. The filings do not explicitly state first patient dosed.
-
A Addex Therapeutics Ltd. 6-K filed 2021-08-05
“On June 29, 2021, the Group announced the initiation of a placebo-controlled Phase 2b/3 pivotal clinical trial of dipraglurant in PD-LID.” ✓ confirmed on the page
-
A Addex Therapeutics Ltd. 6-K filed 2021-08-05
“a placebo-controlled Phase 2b/3 pivotal clinical trial of dipraglurant in PD-LID announced by the Group on June 29, 2021” ✓ confirmed on the page
-
A Addex Therapeutics Ltd. 20-F filed 2022-03-10
“We are conducting a placebo-controlled Phase 2b/3 pivotal clinical trial of dipraglurant in PD-LID patients since June 2021.” ✓ confirmed on the page
Checked 26 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Dose
- Deliverable
- pivotal study of dipraglurant for PD-LID
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Claude (Anthropic), read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Addex Therapeutics Ltd.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-ADXN-023993 · Corrections policy